Synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent
Due to their role in cell growth and survival, HDAC (II), JAK 2 and EGFR receptors are important targets in many chemotherapies that aim to produce their biological response in malignancy solid tumors. In this work, several 4-hydroxybenzamide analogues coupled with 1,3-benzodioxole, a,ß-unsaturated...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/182e3f267666411a9cef620cc101cd8f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:182e3f267666411a9cef620cc101cd8f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:182e3f267666411a9cef620cc101cd8f2021-11-14T04:31:26ZSynthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent1878-535210.1016/j.arabjc.2021.103510https://doaj.org/article/182e3f267666411a9cef620cc101cd8f2022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1878535221005256https://doaj.org/toc/1878-5352Due to their role in cell growth and survival, HDAC (II), JAK 2 and EGFR receptors are important targets in many chemotherapies that aim to produce their biological response in malignancy solid tumors. In this work, several 4-hydroxybenzamide analogues coupled with 1,3-benzodioxole, a,ß-unsaturated carbonyl, and tert-butyl ester bases small molecules were synthesized via imidation, EDC coupling, and etherification reactions, then bio-active 4-hydroxybenzamide analogues were studied using quantum calculations and molecular docking. The Frontier molecular orbitals and energy gap values were calculated using Time-Dependent Density Functional Theory (TD-DFT). Docking results showed A and E as potent JAK2 inhibitors. B, C, and F may be good HDAC II inhibitors. D may act as a potent EGFR inhibitor. These were followed by cytotoxic evaluation of 4-hydroxybenzamide analogues on human estrogen receptor breast cancer cells (MCF-7), metastatic breast adenocarcinome cancer cells (MDA-MB-231), and fibroblast cells (NIH/3T3) respectively. Molecule E was found to have insignificant apoptosis against MCF 7 cell line and MDM-MD-231 cell lines with IC50 value 5.0 µg⁄mL and 5.0 µg⁄mL respectively.Chia Hui LowHabsah MohamadSiti Fatimah Zaharah MustafaKhamsah Suryati MohdNor Elani Mat NafiElsevierarticleBenzamide analoguesHistone deacetylase II (HDAC II) enzymesJanus kinase (JAK2) enzymesEpidermal growth factor receptor (EGFR)CytotoxicChemistryQD1-999ENArabian Journal of Chemistry, Vol 15, Iss 1, Pp 103510- (2022) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Benzamide analogues Histone deacetylase II (HDAC II) enzymes Janus kinase (JAK2) enzymes Epidermal growth factor receptor (EGFR) Cytotoxic Chemistry QD1-999 |
spellingShingle |
Benzamide analogues Histone deacetylase II (HDAC II) enzymes Janus kinase (JAK2) enzymes Epidermal growth factor receptor (EGFR) Cytotoxic Chemistry QD1-999 Chia Hui Low Habsah Mohamad Siti Fatimah Zaharah Mustafa Khamsah Suryati Mohd Nor Elani Mat Nafi Synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent |
description |
Due to their role in cell growth and survival, HDAC (II), JAK 2 and EGFR receptors are important targets in many chemotherapies that aim to produce their biological response in malignancy solid tumors. In this work, several 4-hydroxybenzamide analogues coupled with 1,3-benzodioxole, a,ß-unsaturated carbonyl, and tert-butyl ester bases small molecules were synthesized via imidation, EDC coupling, and etherification reactions, then bio-active 4-hydroxybenzamide analogues were studied using quantum calculations and molecular docking. The Frontier molecular orbitals and energy gap values were calculated using Time-Dependent Density Functional Theory (TD-DFT). Docking results showed A and E as potent JAK2 inhibitors. B, C, and F may be good HDAC II inhibitors. D may act as a potent EGFR inhibitor. These were followed by cytotoxic evaluation of 4-hydroxybenzamide analogues on human estrogen receptor breast cancer cells (MCF-7), metastatic breast adenocarcinome cancer cells (MDA-MB-231), and fibroblast cells (NIH/3T3) respectively. Molecule E was found to have insignificant apoptosis against MCF 7 cell line and MDM-MD-231 cell lines with IC50 value 5.0 µg⁄mL and 5.0 µg⁄mL respectively. |
format |
article |
author |
Chia Hui Low Habsah Mohamad Siti Fatimah Zaharah Mustafa Khamsah Suryati Mohd Nor Elani Mat Nafi |
author_facet |
Chia Hui Low Habsah Mohamad Siti Fatimah Zaharah Mustafa Khamsah Suryati Mohd Nor Elani Mat Nafi |
author_sort |
Chia Hui Low |
title |
Synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent |
title_short |
Synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent |
title_full |
Synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent |
title_fullStr |
Synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent |
title_full_unstemmed |
Synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent |
title_sort |
synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent |
publisher |
Elsevier |
publishDate |
2022 |
url |
https://doaj.org/article/182e3f267666411a9cef620cc101cd8f |
work_keys_str_mv |
AT chiahuilow synthesisandcomputationalstudyof4hydroxylbenzamideanalogousaspotentialantibreastcanceragent AT habsahmohamad synthesisandcomputationalstudyof4hydroxylbenzamideanalogousaspotentialantibreastcanceragent AT sitifatimahzaharahmustafa synthesisandcomputationalstudyof4hydroxylbenzamideanalogousaspotentialantibreastcanceragent AT khamsahsuryatimohd synthesisandcomputationalstudyof4hydroxylbenzamideanalogousaspotentialantibreastcanceragent AT norelanimatnafi synthesisandcomputationalstudyof4hydroxylbenzamideanalogousaspotentialantibreastcanceragent |
_version_ |
1718429941767340032 |